California Public Employees Retirement System Cyclerion Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.18 - $4.29 $98,313 - $193,470	-45,098 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$2.25 - $7.12 $2,025 - $6,408	-900 Reduced 1.96%	45,098 $138,000
Q3 2020 Nov 05, 2020	BUY	$3.46 - $8.39 $60,896 - $147,664	17,600 Added 61.98%	45,998 $280,000
Q4 2019 Jan 27, 2020	SELL	$1.8 - $13.43 $8,820 - $65,807	-4,900 Reduced 14.72%	28,398 $77,000
Q3 2019 Oct 31, 2019	BUY	$8.12 - $14.54 $56,174 - $100,587	6,918 Added 26.22%	33,298 $404,000
Q2 2019 Aug 15, 2019	BUY	$9.6 - $22.85 $253,248 - $602,783	26,380 New	26,380 $302,000

Others Institutions Holding CYCN

# of Institutions

Shares Held

293K

Call Options Held

Put Options Held

Trustcore Financial Services, LLC

293K
Shares

$933,537
0.02% of portfolio

View Full List

About Cyclerion Therapeutics, Inc.

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

More about CYCN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account